Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Study of the Link Between Complement Activation and IgA Nephropathy Severity — Stella

Home/IgA Nephropathy Severity in Kidney Transplantation/Study of the Link Between Complement Activation and IgA Nephropathy Severity

View on ClinicalTrials.gov

Recruiting

Back to IgA Nephropathy Severity in Kidney Transplantation trials

Study of the Link Between Complement Activation and IgA Nephropathy Severity

Trial locations(1 site)

France

Service de néphrologie, Strasbourg

Key details

Sponsor

University Hospital, Strasbourg, France

Enrollment target

~400 participants

Started

May 2022

Primary completion

May 2027

Age range

18 Years and older

Last updated August 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.